• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Flumequine Sodium

Flumequine Sodium

Product ID F4881
Cas No. 42835-68-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $56.00 In stock
5 g $180.00 In stock
25 g $561.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Flumequine is a fluoroquinolone antibiotic commonly used in veterinary medicine. Flumequine exhibits antibacterial efficacy through the inhibition of bacterial DNA gyrase. This compound also displays other activity, inhibiting GABA-A receptors in the ileum, and displays cancer-related activity in the liver, although reports conflict as to whether flumequine is chemopreventive or carcinogenic. Additionally, this compound was previously explored as a treatment for urinary tract infection in humans, although is not currently used in that manner.

Product Info

Cas No.

42835-68-7

Purity

≥98%

Formula

C14H11FNNaO3

Formula Wt.

283.23

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

F4881 MSDS PDF

Info Sheet

F4881 Info Sheet PDF

References

Kuroiwa Y, Umemura T, Nishikawa A, et al. Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice. Arch Toxicol. 2007 Jan;81(1):63-9. PMID: 16802149.

Vik-Mo FT, Bergh O, Samuelsen OB. Efficacy of orally administered flumequine in the treatment of vibriosis caused by Listonella anguillarum in atlantic cod Gadus morhua. Dis Aquat Organ. 2005 Nov 9;67(1-2):87-92. PMID: 16385813.

Koutsoviti-Papadopoulou M, Kounenis G, Elezoglou V. Inhibitory effect of flumequine, enoxacin and norfloxacin on the GABA-induced contractile effect on the guinea pig ileum. Gen Pharmacol. 1995 Oct;26(6):1391-5. PMID: 7590136.

Schena FP, Gesualdo L, Caracciolo G. A multicentre study of flumequine in the treatment of urinary tract infections. J Antimicrob Chemother. 1988 Jan;21(1):101-6. PMID: 3356617.

Smith JT. The mode of action of 4-quinolones and possible mechanisms of resistance. J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9. PMID: 3542946.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • L3550

    Limonin

    Furanolactone found in citrus fruits.

    ≥98%
  • L8276

    Luteinizing Hormone Releasing Hormone

    Endogenous peptide hormone; GnRH agonist.

    ≥98%
  • D3449

    Dimethoxycurcumin

    Curcumin derivative.

    ≥98%
  • G4518

    Glucaric Acid Calcium Tetrahydrate

    Oxidized non-cylic hexose sugar.

    ≥98%
  • L0250

    Laminin Peptide SIKVAV

    Laminin-derived hexapeptide.

    ≥98%
  • F4482

    Fluvastatin Sodium

    Statin; HMG-CoA reductase inhibitor, potential ...

    ≥98%
  • G1745

    Gemcitabine Hydrochloride

    Nucleoside (deoxycytidine) analog; ribonucleoti...

    ≥98%
  • U6873

    Ursodeoxycholic Acid

    Endogenous secondary bile acid.

    ≥98%
  • I5753

    Ionomycin Calcium

    Polyether Ca2+ ionophore.

    ≥98%
  • A4849

    Amyloid-β (25-35)

    Endogenous APP peptide cleavage product, primar...

    ≥95%
  • W2933

    WHI-P131

    JAK3 and EGFR inhibitor.

    ≥99%
  • B1992

    Bexarotene

    RXR agonist.

    ≥98%
  • L5658

    Lonidamine

    Hexokinase inhibitor, aerobic glycolysis inhibi...

    ≥98%
  • C2916

    Chenodeoxycholic Acid

    Endogenous bile acid; FXR agonist.

    ≥98%
  • C9711

    Cyclovirobuxine D

    Found in Buxus; hERG K+ channel inhibitor.

    ≥97%
  • L1982

    Leupeptin Hemisulfate

    Protease inhibitor.

    ≥95%
  • P1761

    Pepstatin

    Aspartyl protease inhibitor.

    ≥98%
  • P7057

    Protodioscin

    Saponin found in Dioscorea; Na+/K+ ATPase and C...

    ≥98%
  • P3269

    Piroxicam

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • C0168

    Canthaxanthin

    Carotenoid terpene pigment found in various pla...

    ≥9% (product contains stabilizers)

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only